Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018139703) PHARMACEUTICAL COMPOSITION FOR TREATING COLORECTAL DISEASE CONTAINING CYSTATIN AND A PROTEIN DERIVED FROM LACTIC ACID BACTERIA
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/139703 International Application No.: PCT/KR2017/002512
Publication Date: 02.08.2018 International Filing Date: 08.03.2017
IPC:
A61K 38/16 (2006.01) ,A61K 38/00 (2006.01) ,A61K 35/744 ,A61K 35/747 ,A23L 33/18 (2016.01) ,A23L 33/135 (2016.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
[IPC code unknown for A61K 35/744][IPC code unknown for A61K 35/747][IPC code unknown for A23L 33/18][IPC code unknown for A23L 33/135]
Applicants:
CELL BIOTECH CO., LTD. [KR/KR]; 50, Aegibong-ro 409beon-gil, Wolgot-myeon, Gimpo-si, Gyeonggi-do 10003, KR
Inventors:
CHUNG, Myung Jun; KR
Agent:
HONESTY & JR PARTNERS INTELLECTUAL PROPERTY LAW GROUP; 5F, 615 Sunreung-ro, Gangnam-gu, Seoul 06103, KR
Priority Data:
10-2017-001196725.01.2017KR
Title (EN) PHARMACEUTICAL COMPOSITION FOR TREATING COLORECTAL DISEASE CONTAINING CYSTATIN AND A PROTEIN DERIVED FROM LACTIC ACID BACTERIA
(FR) COMPOSITION PHARMACEUTIQUE POUR LE TRAITEMENT D'UNE MALADIE COLORECTALE CONTENANT DE LA CYSTATINE ET UNE PROTÉINE DÉRIVÉE DE BACTÉRIES LACTIQUES
Abstract:
(EN) The present invention relates to a pharmaceutical composition for treating colorectal disease, which contains cystatin and a protein derived from lactic acid bacteria. The pharmaceutical composition of the present invention, which contains cystatin and the protein derived from lactic acid bacteria, exhibits a significantly increased inhibitory effect against colorectal cancer compared to when cystatin and the protein derived from lactic acid bacteria are used alone. Thus, the pharmaceutical composition of the present invention will be effectively used as a therapeutic agent against colorectal cancer in the medical field.
(FR) La présente invention concerne une composition pharmaceutique pour le traitement d'une maladie colorectale, qui contient de la cystatine et une protéine dérivée de bactéries lactiques. La composition pharmaceutique de la présente invention, qui contient de la cystatine et la protéine dérivée de bactéries lactiques, présente un effet inhibiteur significativement accru contre le cancer colorectal par rapport au cas où la cystatine et la protéine dérivée de bactéries lactiques sont utilisées seules. Ainsi, la composition pharmaceutique de la présente invention sera efficacement utilisée en tant qu'agent thérapeutique contre le cancer colorectal dans le domaine médical.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)